Female Contraceptive Market Research Report by Contraceptive Drug (Contraceptive Injections, Contraceptive Pills, Spermicides, and Topical Contraceptives), by Contraceptive Devices (Contraceptive Patches, Contraceptive Sponges, Diaphragms and Caps, Female Condoms, and Intra Uterine Contraceptive Devices (IUCDs)), by Distribution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Female Contraceptive Market is expected to grow from USD 7,807.19 Million in 2020 to USD 10,146.68 Million by the end of 2025.
2. The Global Female Contraceptive Market is expected to grow from EUR 6,845.50 Million in 2020 to EUR 8,896.80 Million by the end of 2025.
3. The Global Female Contraceptive Market is expected to grow from GBP 6,085.66 Million in 2020 to GBP 7,909.27 Million by the end of 2025.
4. The Global Female Contraceptive Market is expected to grow from JPY 833,226.04 Million in 2020 to JPY 1,082,908.04 Million by the end of 2025.
5. The Global Female Contraceptive Market is expected to grow from AUD 11,337.09 Million in 2020 to AUD 14,734.33 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Female Contraceptive to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Contraceptive Drug, the Female Contraceptive Market studied across Contraceptive Injections, Contraceptive Pills, Spermicides, and Topical Contraceptives. The Contraceptive Pills further studied across Hormonal Pills and Non-hormonal Pills.
Based on Contraceptive Devices, the Female Contraceptive Market studied across Contraceptive Patches, Contraceptive Sponges, Diaphragms and Caps, Female Condoms, Intra Uterine Contraceptive Devices (IUCDs), Sub-dermal Contraceptive Implants, and Vaginal Rings.
Based on Distribution Channel, the Female Contraceptive Market studied across Clinic, Hospital Pharmacy, Independent Pharmacy, and Online Platform.
Based on Geography, the Female Contraceptive Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Female Contraceptive Market including Allergan plc, Bayer AG, Cipla Limited, HLL Lifecare Limited, Johnson & Johnson, Mankind Pharma, Merck Sharp & Dohme Corp, Mithra Pharmaceuticals S.A., Pfizer Inc., and Reckitt Benckiser Group plc.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Female Contraceptive Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Female Contraceptive Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Female Contraceptive Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Female Contraceptive Market?
4. What is the competitive strategic window for opportunities in the Global Female Contraceptive Market?
5. What are the technology trends and regulatory frameworks in the Global Female Contraceptive Market?
6. What are the modes and strategic moves considered suitable for entering the Global Female Contraceptive Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Female Contraceptive Market is expected to grow from USD 7,807.19 Million in 2020 to USD 10,146.68 Million by the end of 2025.
2. The Global Female Contraceptive Market is expected to grow from EUR 6,845.50 Million in 2020 to EUR 8,896.80 Million by the end of 2025.
3. The Global Female Contraceptive Market is expected to grow from GBP 6,085.66 Million in 2020 to GBP 7,909.27 Million by the end of 2025.
4. The Global Female Contraceptive Market is expected to grow from JPY 833,226.04 Million in 2020 to JPY 1,082,908.04 Million by the end of 2025.
5. The Global Female Contraceptive Market is expected to grow from AUD 11,337.09 Million in 2020 to AUD 14,734.33 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Female Contraceptive to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Contraceptive Drug, the Female Contraceptive Market studied across Contraceptive Injections, Contraceptive Pills, Spermicides, and Topical Contraceptives. The Contraceptive Pills further studied across Hormonal Pills and Non-hormonal Pills.
Based on Contraceptive Devices, the Female Contraceptive Market studied across Contraceptive Patches, Contraceptive Sponges, Diaphragms and Caps, Female Condoms, Intra Uterine Contraceptive Devices (IUCDs), Sub-dermal Contraceptive Implants, and Vaginal Rings.
Based on Distribution Channel, the Female Contraceptive Market studied across Clinic, Hospital Pharmacy, Independent Pharmacy, and Online Platform.
Based on Geography, the Female Contraceptive Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Female Contraceptive Market including Allergan plc, Bayer AG, Cipla Limited, HLL Lifecare Limited, Johnson & Johnson, Mankind Pharma, Merck Sharp & Dohme Corp, Mithra Pharmaceuticals S.A., Pfizer Inc., and Reckitt Benckiser Group plc.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Female Contraceptive Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Female Contraceptive Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Female Contraceptive Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Female Contraceptive Market?
4. What is the competitive strategic window for opportunities in the Global Female Contraceptive Market?
5. What are the technology trends and regulatory frameworks in the Global Female Contraceptive Market?
6. What are the modes and strategic moves considered suitable for entering the Global Female Contraceptive Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Contraceptive Drug Outlook
3.4. Distribution Channel Outlook
3.5. Contraceptive Devices Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL FEMALE CONTRACEPTIVE MARKET, BY CONTRACEPTIVE DRUG
6.1. Introduction
6.2. Contraceptive Injections
6.3. Contraceptive Pills
6.3.1. Hormonal Pills
6.3.2. Non-hormonal Pills
6.4. Spermicides
6.5. Topical Contraceptives
7. GLOBAL FEMALE CONTRACEPTIVE MARKET, BY CONTRACEPTIVE DEVICES
7.1. Introduction
7.2. Contraceptive Patches
7.3. Contraceptive Sponges
7.4. Diaphragms and Caps
7.5. Female Condoms
7.6. Intra Uterine Contraceptive Devices (IUCDs)
7.7. Sub-dermal Contraceptive Implants
7.8. Vaginal Rings
8. GLOBAL FEMALE CONTRACEPTIVE MARKET, BY DISTRIBUTION CHANNEL
8.1. Introduction
8.2. Clinic
8.3. Hospital Pharmacy
8.4. Independent Pharmacy
8.5. Online Platform
9. AMERICAS FEMALE CONTRACEPTIVE MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Allergan plc
13.2. Bayer AG
13.3. Cipla Limited
13.4. HLL Lifecare Limited
13.5. Johnson & Johnson
13.6. Mankind Pharma
13.7. Merck Sharp & Dohme Corp
13.8. Mithra Pharmaceuticals S.A.
13.9. Pfizer Inc.
13.10. Reckitt Benckiser Group plc
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Contraceptive Drug Outlook
3.4. Distribution Channel Outlook
3.5. Contraceptive Devices Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL FEMALE CONTRACEPTIVE MARKET, BY CONTRACEPTIVE DRUG
6.1. Introduction
6.2. Contraceptive Injections
6.3. Contraceptive Pills
6.3.1. Hormonal Pills
6.3.2. Non-hormonal Pills
6.4. Spermicides
6.5. Topical Contraceptives
7. GLOBAL FEMALE CONTRACEPTIVE MARKET, BY CONTRACEPTIVE DEVICES
7.1. Introduction
7.2. Contraceptive Patches
7.3. Contraceptive Sponges
7.4. Diaphragms and Caps
7.5. Female Condoms
7.6. Intra Uterine Contraceptive Devices (IUCDs)
7.7. Sub-dermal Contraceptive Implants
7.8. Vaginal Rings
8. GLOBAL FEMALE CONTRACEPTIVE MARKET, BY DISTRIBUTION CHANNEL
8.1. Introduction
8.2. Clinic
8.3. Hospital Pharmacy
8.4. Independent Pharmacy
8.5. Online Platform
9. AMERICAS FEMALE CONTRACEPTIVE MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Allergan plc
13.2. Bayer AG
13.3. Cipla Limited
13.4. HLL Lifecare Limited
13.5. Johnson & Johnson
13.6. Mankind Pharma
13.7. Merck Sharp & Dohme Corp
13.8. Mithra Pharmaceuticals S.A.
13.9. Pfizer Inc.
13.10. Reckitt Benckiser Group plc
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL PILLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL PILLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SPERMICIDES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY TOPICAL CONTRACEPTIVES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PATCHES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE SPONGES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGMS AND CAPS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY FEMALE CONDOMS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRA UTERINE CONTRACEPTIVE DEVICES (IUCDS), BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SUB-DERMAL CONTRACEPTIVE IMPLANTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. GLOBAL FEMALE CONTRACEPTIVE MARKET: SCORES
TABLE 112. GLOBAL FEMALE CONTRACEPTIVE MARKET: BUSINESS STRATEGY
TABLE 113. GLOBAL FEMALE CONTRACEPTIVE MARKET: PRODUCT SATISFACTION
TABLE 114. GLOBAL FEMALE CONTRACEPTIVE MARKET: RANKING
TABLE 115. GLOBAL FEMALE CONTRACEPTIVE MARKET: MERGER & ACQUISITION
TABLE 116. GLOBAL FEMALE CONTRACEPTIVE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 117. GLOBAL FEMALE CONTRACEPTIVE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 118. GLOBAL FEMALE CONTRACEPTIVE MARKET: INVESTMENT & FUNDING
TABLE 119. GLOBAL FEMALE CONTRACEPTIVE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 120. GLOBAL FEMALE CONTRACEPTIVE MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL PILLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL PILLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SPERMICIDES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY TOPICAL CONTRACEPTIVES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PATCHES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE SPONGES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGMS AND CAPS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY FEMALE CONDOMS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRA UTERINE CONTRACEPTIVE DEVICES (IUCDS), BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SUB-DERMAL CONTRACEPTIVE IMPLANTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. GLOBAL FEMALE CONTRACEPTIVE MARKET: SCORES
TABLE 112. GLOBAL FEMALE CONTRACEPTIVE MARKET: BUSINESS STRATEGY
TABLE 113. GLOBAL FEMALE CONTRACEPTIVE MARKET: PRODUCT SATISFACTION
TABLE 114. GLOBAL FEMALE CONTRACEPTIVE MARKET: RANKING
TABLE 115. GLOBAL FEMALE CONTRACEPTIVE MARKET: MERGER & ACQUISITION
TABLE 116. GLOBAL FEMALE CONTRACEPTIVE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 117. GLOBAL FEMALE CONTRACEPTIVE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 118. GLOBAL FEMALE CONTRACEPTIVE MARKET: INVESTMENT & FUNDING
TABLE 119. GLOBAL FEMALE CONTRACEPTIVE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 120. GLOBAL FEMALE CONTRACEPTIVE MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL FEMALE CONTRACEPTIVE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL FEMALE CONTRACEPTIVE MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2020 (USD MILLION)
FIGURE 5. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD MILLION)
FIGURE 6. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2020 (USD MILLION)
FIGURE 7. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL FEMALE CONTRACEPTIVE MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL FEMALE CONTRACEPTIVE MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2020 VS 2025 (%)
FIGURE 15. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2025
FIGURE 17. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTIONS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL PILLS, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL PILLS, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SPERMICIDES, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY TOPICAL CONTRACEPTIVES, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2020 VS 2025 (%)
FIGURE 24. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2020 VS 2025 (USD MILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2025
FIGURE 26. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PATCHES, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE SPONGES, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGMS AND CAPS, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY FEMALE CONDOMS, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRA UTERINE CONTRACEPTIVE DEVICES (IUCDS), 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SUB-DERMAL CONTRACEPTIVE IMPLANTS, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2025 (%)
FIGURE 34. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2025 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025
FIGURE 36. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINIC, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, 2020 VS 2025 (USD MILLION)
FIGURE 40. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 41. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 43. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 49. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 50. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 51. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 63. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 74. GLOBAL FEMALE CONTRACEPTIVE MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 75. GLOBAL FEMALE CONTRACEPTIVE MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 76. GLOBAL FEMALE CONTRACEPTIVE MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 77. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL FEMALE CONTRACEPTIVE MARKET, BY TYPE
FIGURE 1. GLOBAL FEMALE CONTRACEPTIVE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL FEMALE CONTRACEPTIVE MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2020 (USD MILLION)
FIGURE 5. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD MILLION)
FIGURE 6. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2020 (USD MILLION)
FIGURE 7. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL FEMALE CONTRACEPTIVE MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL FEMALE CONTRACEPTIVE MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2020 VS 2025 (%)
FIGURE 15. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2025
FIGURE 17. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTIONS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL PILLS, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL PILLS, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SPERMICIDES, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY TOPICAL CONTRACEPTIVES, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2020 VS 2025 (%)
FIGURE 24. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2020 VS 2025 (USD MILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2025
FIGURE 26. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PATCHES, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE SPONGES, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGMS AND CAPS, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY FEMALE CONDOMS, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRA UTERINE CONTRACEPTIVE DEVICES (IUCDS), 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SUB-DERMAL CONTRACEPTIVE IMPLANTS, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2025 (%)
FIGURE 34. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2025 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025
FIGURE 36. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINIC, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, 2020 VS 2025 (USD MILLION)
FIGURE 40. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 41. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 43. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 49. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 50. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 51. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 63. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 74. GLOBAL FEMALE CONTRACEPTIVE MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 75. GLOBAL FEMALE CONTRACEPTIVE MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 76. GLOBAL FEMALE CONTRACEPTIVE MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 77. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL FEMALE CONTRACEPTIVE MARKET, BY TYPE
